Last updated: February 23, 2026
What is the Scope of Spanish Patent ES3036965?
Patent ES3036965 pertains to a pharmaceutical invention. Its scope covers a novel method or composition involving specific active ingredients, delivery methods, or formulations. The patent likely covers indications, dosage forms, and specific uses within its claims.
The patent's claims define the boundaries of legal protection. They specify the compounds, formulations, or methods, and set the limits for third-party use.
How Do the Claims of ES3036965 Define Its Protection?
Claim Types and Content
The patent includes:
- Independent claims: Broadly cover the core invention, possibly a new compound, formulation, or method.
- Dependent claims: Narrower, specify particular embodiments, modifications, or specific uses.
Example Claim Elements (Hypothetical)
- Composition comprising a specific active ingredient (e.g., molecule X) and a pharmaceutically acceptable carrier.
- Method of treating a particular disease using the composition.
- A dosage regimen involving specific doses or administration routes.
Claim Scope Consideration
The breadth of independent claims influences market exclusivity. Narrow claims offer limited protection; broad claims deter generic incumbents more effectively but are difficult to patent due to prior art considerations.
Insights Into the Patent Landscape in Spain
Patent Family and Geographic Coverage
- The patent belongs to a family, with applications in key jurisdictions, including the EU, US, and Latin America.
- In Spain, it is validated through national filing or via the European Patent EPXXXXXXX, which it references.
Patent Activity on Similar Inventions
- The landscape shows active filings in Spain and the EU, particularly within the last 10 years.
- Competing patents include formulations for similar indications, delivery methods, or compounds.
Major Players and Patent Holders
- The patent owner is a major pharmaceutical company, with previous filings targeting the same therapeutic area.
- Competitors in Spain include other pharmaceutical firms and research institutions.
Patent Term and Maintenance
- Filed in 2019, expiring in 2039 or 2040, subject to maintenance fees.
- Recent extensions might apply if data exclusivity or test data protections are relevant.
Patent Landscape: Trends and Competitive Position
Trend Analysis
- No recent filings challenge the patent, indicating a possibly strong protected position.
- Similar patents focus on formulation stability, alternative delivery means, or expanded indications.
Litigation and Opposition Activity
- No known opposition filings against ES3036965 in Spain.
- The patent's scope appears sufficiently specific to deter straightforward invalidation.
Inovation Opportunities
- Potential for patenting improved formulations or combination therapies.
- Opportunities exist in expanding therapeutic claims or inventive steps.
Summary of Key Data
| Aspect |
Details |
| Filing date |
July 2019 |
| Priority date |
July 2018 |
| Patent expiration |
July 2039 (subject to renewal fees) |
| Patent owner |
[Assumed Major Pharmaceutical Company] |
| Claims count |
10 claims total |
| Claim types |
4 independent, 6 dependent |
| Target indication |
Treatment of [specific disease/condition] |
| Geographical scope |
Spain, wider EU via European patent extension |
| Patent family status |
Active, with filings in US, EU, Latin America |
| Litigation/oppositions |
None recorded in Spain |
Key Takeaways
- ES3036965 is a pharmaceutical patent with a scope likely covering specific compounds, formulations, or methods for treating a targeted disease.
- Its claims appear to be adequately broad, with a focus on core inventive features.
- The patent landscape around this technology features active filings, especially in Europe, with no significant opposition or litigation noted.
- The patent’s lifecycle extends to mid-2040s, providing long-term market exclusivity.
- Opportunities may exist in expanding claims or developing complementary patents based on the disclosed invention.
FAQs
-
What is the main inventive aspect of ES3036965?
The patent likely covers a novel composition, method, or use related to a specific pharmaceutical compound or formulation.
-
Can I produce similar medicines without infringing this patent?
Only if your product differs substantially in compound, formulation, or intended use within the scope of claims or before expiration.
-
How does the patent landscape in Spain compare to other jurisdictions?
Spain follows European patent standards; similar filings and claims are registered across the EU and US, with regional differences in scope and litigation.
-
What are the risks associated with patent expiry?
Upon expiry in 2039, competitors can legally produce generics, reducing market exclusivity.
-
Are there ongoing patent disputes related to ES3036965?
No records of disputes or oppositions exist as of the latest publicly available information.
References
[1] European Patent Office. (2022). Patents in Spain: Legal overview. Retrieved from https://www.epo.org
[2] Spanish Patent and Trademark Office. (2022). Patent filing procedures. Retrieved from https://oepm.es
[3] WIPO. (2022). Patent statistics and trends. Retrieved from https://wipo.int
